Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
2.

Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.

Fisher JA, Fikry C, Troxel AB.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):108-13. Review.

3.

A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population [Internet].

van Ballegooijen M, Habbema JDF, Boer R, Zauber AG, Brown ML.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 9.

4.

Screening of colorectal cancer.

Winawer SJ.

Surg Oncol Clin N Am. 2005 Oct;14(4):699-722. Review.

PMID:
16226687
5.

Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer [Internet].

Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Dec 20.

6.

Options for screening for colorectal cancer.

Atkin W.

Scand J Gastroenterol Suppl. 2003;(237):13-6. Review.

PMID:
12797674
7.

Cost-effectiveness in the prevention of colorectal cancer.

Sonnenberg A.

Gastroenterol Clin North Am. 2002 Dec;31(4):1069-91. Review.

PMID:
12489279
8.

Screening for colorectal cancer: what is the most cost-effective approach?

Bolin TD, Lapsley HM, Korman MG.

Med J Aust. 2001 Mar 19;174(6):298-301. Review.

PMID:
11297120
9.

Clinical significance of small polyps found during screening with flexible sigmoidoscopy.

Farraye FA, Wallace M.

Gastrointest Endosc Clin N Am. 2002 Jan;12(1):41-51. Review.

PMID:
11916160
10.

Evidence for colorectal cancer screening.

Bretthauer M.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):417-25. doi: 10.1016/j.bpg.2010.06.005. Review.

PMID:
20833346
11.

Cost Effectiveness of Colorectal Cancer Screening Strategies.

Patel SS, Kilgore ML.

Cancer Control. 2015 Apr;22(2):248-58. Review.

12.

Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Dinh TA, Alperin P, Walter LC, Smith R.

J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. Review.

13.

Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.

Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B.

Eur J Gastroenterol Hepatol. 2006 Apr;18(4):427-33. Review.

PMID:
16538116
14.

Cost-effectiveness of colonoscopy.

Zauber AG.

Gastrointest Endosc Clin N Am. 2010 Oct;20(4):751-70. doi: 10.1016/j.giec.2010.07.008. Review.

16.

Current status of screening for colorectal cancer.

Garborg K, Holme Ø, Løberg M, Kalager M, Adami HO, Bretthauer M.

Ann Oncol. 2013 Aug;24(8):1963-72. doi: 10.1093/annonc/mdt157. Epub 2013 Apr 25. Review.

PMID:
23619033
17.

Participation in colorectal cancer screening: a review.

Vernon SW.

J Natl Cancer Inst. 1997 Oct 1;89(19):1406-22. Review.

PMID:
9326910
18.

Screening guidelines for colorectal cancer.

Bond JH.

Am J Med. 1999 Jan 25;106(1A):7S-10S. Review.

PMID:
10089107
19.

Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ.

Am J Gastroenterol. 2017 Jul;112(7):1016-1030. doi: 10.1038/ajg.2017.174. Epub 2017 Jun 6. Review.

PMID:
28555630
20.

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary.

Tinmouth J, Vella ET, Baxter NN, Dubé C, Gould M, Hey A, Ismaila N, McCurdy BR, Paszat L.

Can J Gastroenterol Hepatol. 2016;2016:2878149. doi: 10.1155/2016/2878149. Epub 2016 Aug 14. Review.

Supplemental Content

Support Center